C/EBP{alpha} is required for pulmonary cytoprotection during hyperoxia.
about
Kruppel-like factor 5 controls villus formation and initiation of cytodifferentiation in the embryonic intestinal epitheliumA systems approach to mapping transcriptional networks controlling surfactant homeostasis.Comparative proteomic analysis of lung lamellar bodies and lysosome-related organellesConditional deletion of Abca3 in alveolar type II cells alters surfactant homeostasis in newborn and adult mice.Oxygen differentially affects the hox proteins Hoxb5 and Hoxa5 altering airway branching and lung vascular formation.CCAAT/enhancer binding protein-α regulates the protease/antiprotease balance required for bronchiolar epithelium regeneration.Gene regulatory network analysis supports inflammation as a key neurodegeneration process in prion disease.CCAAT/enhancer-binding protein-α suppresses lung tumor development in mice through the p38α MAP kinase pathway.Silencing hyperoxia-induced C/EBPα in neonatal mice improves lung architecture via enhanced proliferation of alveolar epithelial cellsConditional deletion of Nrf2 in airway epithelium exacerbates acute lung injury and impairs the resolution of inflammation.A Relationship between Epithelial Maturation, Bronchopulmonary Dysplasia, and Chronic Obstructive Pulmonary Disease.Single-cell mRNA quantification and differential analysis with Census.Abca3 haploinsufficiency is a risk factor for lung injury induced by hyperoxia or mechanical ventilation in a murine model.Kruppel-like factor 5 is required for formation and differentiation of the bladder urotheliumFOXM1 promotes allergen-induced goblet cell metaplasia and pulmonary inflammation.Foxm1 transcription factor is critical for proliferation and differentiation of Clara cells during development of conducting airways
P2860
Q28593611-D1072D60-F6B8-4DBE-9AC5-E3AF9CCD3E2FQ33640757-DB4E77B9-4CDC-428F-9DF7-D2B225112375Q33813328-F7B8A72A-3FCA-43D7-8FA5-355283C3E57DQ33840506-1BCC2DC8-B683-4166-AEF3-0FBDC81839EAQ34195890-3A12F6D5-297E-4296-AF9D-3C2EF108713FQ34288146-8DF9E882-EA6B-4D91-BF61-4F0D988B3EDBQ34446150-722BF5AA-7F5C-4C01-A29B-347BD7344280Q34599904-78788680-2E59-4845-B6C9-005C38894130Q35159757-607A53AE-AEED-45A1-B04A-ACCB45E5EB31Q35684800-16A458DB-3BB8-43FE-8081-9893B16C0011Q36520558-80031255-CF02-4349-9B70-7D528DBDDD10Q37672206-D4F688BB-F2C2-48F7-8F0A-9354559EC051Q38313892-13FDF709-F2E1-4856-B84F-54D94D85911CQ38570411-675CB36C-8520-4041-9371-2C04DCF76400Q39245324-266186D9-8AB4-4555-8375-D1D878A59864Q42326807-3281FC9B-C03E-4F13-84DC-A89840E26373
P2860
C/EBP{alpha} is required for pulmonary cytoprotection during hyperoxia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
C/EBP{alpha} is required for pulmonary cytoprotection during hyperoxia.
@en
C/EBP{alpha} is required for pulmonary cytoprotection during hyperoxia.
@nl
type
label
C/EBP{alpha} is required for pulmonary cytoprotection during hyperoxia.
@en
C/EBP{alpha} is required for pulmonary cytoprotection during hyperoxia.
@nl
prefLabel
C/EBP{alpha} is required for pulmonary cytoprotection during hyperoxia.
@en
C/EBP{alpha} is required for pulmonary cytoprotection during hyperoxia.
@nl
P2093
P2860
P1476
C/EBP{alpha} is required for pulmonary cytoprotection during hyperoxia.
@en
P2093
Angelica Schehr
Chika Saegusa
Jeffrey A Whitsett
Machiko Ikegami
Shawn Grant
P2860
P304
P356
10.1152/AJPLUNG.00094.2009
P577
2009-05-22T00:00:00Z